RxDoctor Payments Data

Samuel Neuhut, MD

Psychiatry · Aventura, FLNPI 1750609244

Payments from drug & device makers

$11,542in general payments, 2019–2025

Across 209 payments — averaging $55.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$7K
  • AbbVie$864
  • Teva Pharmaceuticals USA, Inc.$742
  • Johnson & Johnson$600
  • Otsuka America Pharmaceutical, Inc.$440
  • Lundbeck LLC$372
  • plus $1K from 18 others

What the payments were for

  • Speaking & faculty fees$6,57957%
  • Travel & lodging$80%
  • Food & beverage$4,77241%
  • Education$1832%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,542 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$154,645
Medicare patients
225
Services billed
1,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide39$22,831
Aripiprazole76$5,477
Venlafaxine Hcl ErVenlafaxine Hcl134$4,460
Duloxetine Hcl131$3,967
Bupropion XlBupropion Hcl120$3,078
Mirtazapine109$2,280
Clonazepam245$1,791
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$1,389
Trazodone Hcl181$1,333
Buspirone Hcl70$1,288
Lamotrigine119$1,170
Sertraline Hcl102$1,156
Hydroxyzine Hcl33$958
Quetiapine Fumarate59$903
Lorazepam128$870

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$142$22,83139 claims
Almatica Pharma LLCSertraline Hcl$371$1,156102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Aventura

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →